Status: Recruiting
A Clinical Study to Evaluate the Safety, Tolerability, and Efficacy of BBM-D101 in the Treatment of Duchenne Muscular Dystrophy.
The purpose of the study is to evaluate the safety, tolerability, and efficacy of BBM-D101 to treat participants with Duchenne Muscular Dystrophy.
Participants needed: 9
Trial details
Phase: Phase 1, Phase 2Age: 4-9Biological sex: MaleType: InterventionalSponsor: Belief BioMed (Beijing) Co., LtdUpdated: Dec 4, 2025Locations: 1
Eligibility criteria
The Participants and/or his legal guardian must fully understand the purpose, na... [+8]
Positive for hepatitis B surface antigen (HBsAg), hepatitis B virus deoxyribonuc... [+11]